Altered expression of myogenic regulatory factors in the mouse model of amyotrophic lateral sclerosis

Neurodegenerative Diseases

Volumn 8, Issue 5, 2011, Pages 386-396

  Manzano, Raquel ^a   Toivonen, Janne M ^a   Oliván, Sara ^a   Calvo, Ana C ^a   Moreno Igoa, Maria ^a   Muñoz, Maria J ^a   Zaragoza, Pilar ^a   García Redondo, Alberto ^b   Osta, Rosario ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b Instituto de Investigación Sanitaria Hospital 12 de Octubre ^*  (Spain)

Author keywords

Amyotrophic lateral sclerosis; Denervation; Motor neuron disease; Muscle; Myogenic regulatory factor

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CXCR4; COPPER ZINC SUPEROXIDE DISMUTASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYOD1 PROTEIN; MYOGENIC FACTOR; MYOGENIC FACTOR 5; MYOGENIN; NICOTINIC RECEPTOR; RANTES; TRANSCRIPTION FACTOR PAX7;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GASTROCNEMIUS MUSCLE; GENETIC TRANSCRIPTION; MALE; MOUSE; MUSCLE DENERVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SOLEUS MUSCLE; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MICE; MICE, TRANSGENIC; MYOGENIC REGULATORY FACTORS; SUPEROXIDE DISMUTASE;

EID: 79958810150     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000324159     Document Type: Article

References (90)

1. Cleveland DW, Rothstein JD: From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001;2:806-819. (Pubitemid 33674062)
2. Rosen DR: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;364:362.
3. Julien JP, Kriz J: Transgenic mouse models of amyotrophic lateral sclerosis. Biochim Biophys Acta 2006;1762:1013-1024.
4. Gurney ME: Transgenic-mouse model of amyotrophic lateral sclerosis. N Engl J Med 1994;331:1721-1722.
5. Yim MB, Kang JH, Yim HS, Kwak HS, Chock PB, Stadtman ER: A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in K m for hydrogen peroxide. Proc Natl Acad Sci USA 1996;93:5709-5714. (Pubitemid 26190744)
6. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW: Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1995;92:689-693.
7. Dupuis L, Loeffler JP: Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr Opin Pharmacol 2009;9:341-346.
8. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD: Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 2004;185:232-240.
9. Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P: Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 2000;20:2534-2542. (Pubitemid 30220340)
10. Hegedus J, Putman CT, Gordon T: Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2007;28:154-164. (Pubitemid 47615455)
11. Lino MM, Schneider C, Caroni P: Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci 2002;22:4825-4832. (Pubitemid 37465597)
12. Pramatarova A, Laganière J, Roussel J, Brisebois K, Rouleau GA: Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci 2001;21:3369-3374. (Pubitemid 32422802)
13. Jaarsma D, Teuling E, Haasdijk ED, de Zeeuw CI, Hoogenraad CC: Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice. J Neurosci 2008;28:2075-2088. (Pubitemid 351317636)
14. Boillée S, vande Velde C, Cleveland DW: ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006;52:39-59.
15. Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, Couratier P: Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 2009;256:1236-1242.
16. Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrère B, Couratier P: Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 2001;74:328-334. (Pubitemid 32802018)
17. Dupuis L, Oudart H, René F, Gonzalez de Aguilar JL, Loeffler JP: Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA 2004;101:11159-11164. (Pubitemid 38989600)
18. Dupuis L, Gonzalez de Aguilar JL, Echaniz-Laguna A, Eschbach J, René F, Oudart H, Halter B, Huze C, Schaeffer L, Bouillaud F, Loeffler JP: Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One 2009;4:e5390.
19. Jokic N, Gonzalez de Aguilar JL, Dimou L, Lin S, Fergani A, Ruegg MA, Schwab ME, Dupuis L, Loeffler JP: The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep 2006;7:1162-1167. (Pubitemid 44660574)
20. Jokic N, Gonzalez de Aguilar JL, Pradat PF, Dupuis L, Echaniz-Laguna A, Muller A, Dubourg O, Seilhean D, Hauw JJ, Loeffler JP, Meininger V: Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann Neurol 2005;57:553-556. (Pubitemid 40471166)
21. Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, Boncompagni S, Belia S, Wannenes F, Nicoletti C, del Prete Z, Rosenthal N, Molinaro M, Protasi F, Fano G, Sandri M, Musaro A: Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 2008;8:425-436.
22. Wong M, Martin LJ: Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet 2010;19:2284-2302.
23. Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G: Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest 2010;120:11-19.
24. le Grand F, Rudnicki M: Satellite and stem cells in muscle growth and repair. Development 2007;134:3953-3957.
25. Mauro A: Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961;9:493-495.
26. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA: Pax7 is required for the specification of myogenic satellite cells. Cell 2000;102:777-786.
27. Zammit PS, Relaix F, Nagata Y, Ruiz AP, Collins CA, Partridge TA, Beauchamp JR: Pax7 and myogenic progression in skeletal muscle satellite cells. J Cell Sci 2006;119:1824-1832. (Pubitemid 43811008)
28. Rudnicki MA, le Grand F, McKinnell I, Kuang S: The molecular regulation of muscle stem cell function. Cold Spring Harb Symp Quant Biol 2008;73:323-331.
29. Cooper RN, Tajbakhsh S, Mouly V, Cossu G, Buckingham M, Butler-Browne GS: In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J Cell Sci 1999;112:2895-2901.
30. Smith CK 2nd, Janney MJ, Allen RE: Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle satellite cells. J Cell Physiol 1994;159:379-385. (Pubitemid 24141945)
31. Yablonka-Reuveni Z, Rivera AJ: Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers. Dev Biol 1994;164:588-603. (Pubitemid 24269245)
32. Buonanno A, Apone L, Morasso MI, Beers R, Brenner HR, Eftimie R: The MyoD family of myogenic factors is regulated by electrical activity: isolation and characterization of a mouse Myf-5 cDNA. Nucleic Acids Res 1992;20:539-544.
33. Duclert A, Piette J, Changeux JP: Influence of innervation of myogenic factors and acetylcholine receptor alpha-subunit mRNAs. Neuroreport 1991;2:25-28.
34. Eftimie R, Brenner HR, Buonanno A: Myogenin and MyoD join a family of skeletal muscle genes regulated by electrical activity. Proc Natl Acad Sci USA 1991;88:1349-1353. (Pubitemid 21916222)
35. Voytik SL, Przyborski M, Badylak SF, Konieczny SF: Differential expression of muscle regulatory factor genes in normal and denervated adult rat hindlimb muscles. Dev Dyn 1993;198:214-224. (Pubitemid 24010915)
36. Witzemann V, Sakmann B: Differential regulation of MyoD and myogenin mRNA levels by nerve induced muscle activity. FEBS Lett 1991;282:259-264.
37. Halter B, Gonzalez de Aguilar JL, René F, Petri S, Fricker B, Echaniz-Laguna A, Dupuis L, Larmet Y, Loeffler JP: Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med 2010;48:915-923.
38. Ferrari G, Cusella-de Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F: Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528-1530. (Pubitemid 28217075)
39. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC: Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999;401:390-394. (Pubitemid 29454964)
40. Otto A, Collins-Hooper H, Patel K: The origin, molecular regulation and therapeutic potential of myogenic stem cell populations. J Anat 2009;215:477-497.
41. Polesskaya A, Seale P, Rudnicki MA: Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell 2003;113:841-852. (Pubitemid 36792029)
42. ten Broek RW, Grefte S, von den Hoff JW: Regulatory factors and cell populations involved in skeletal muscle regeneration. J Cell Physiol 2010;224:7-16.
43. Baron P, Bussini S, Cardin V, Corbo M, Conti G, Galimberti D, Scarpini E, Bresolin N, Wharton SB, Shaw PJ, Silani V: Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve 2005;32:541-544. (Pubitemid 41395989)
44. Henkel JS, Beers DR, Siklos L, Appel SH: The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol Cell Neurosci 2006;31:427-437. (Pubitemid 43358017)
45. Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR, Appel SH: Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 2004;55:221-235.
46. Malaspina A, Kaushik N, de Belleroche J: Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 2001;77:132-145. (Pubitemid 32245087)
47. Rentzos M, Nikolaou C, Rombos A, Boufidou F, Zoga M, Dimitrakopoulos A, Tsoutsou A, Vassilopoulos D: RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2007;8:283-287. (Pubitemid 47543094)
48. Tateishi T, Yamasaki R, Tanaka M, Matsushita T, Kikuchi H, Isobe N, Ohyagi Y, Kira J: CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis. J Neuroimmunol 2010;222:76-81.
49. Zhang R, Gascon R, Miller RG, Gelinas DF, Mass J, Lancero M, Narvaez A, McGrath MS: MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol 2006;179:87-93. (Pubitemid 44468128)
50. Corti S, Salani S, del Bo R, Sironi M, Strazzer S, D'Angelo MG, Comi GP, Bresolin N, Scarlato G: Chemotactic factors enhance myogenic cell migration across an endothelial monolayer. Exp Cell Res 2001;268:36-44. (Pubitemid 32678858)
51. Griffin CA, Apponi LH, Long KK, Pavlath GK: Chemokine expression and control of muscle cell migration during myogenesis. J Cell Sci 2010;123:3052-3060.
52. Burkholder TJ, Fingado B, Baron S, Lieber RL: Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J Morphol 1994; 221:177-190. (Pubitemid 2123416)
53. -ΔΔCT method. Methods 2001;25:402-408.
54. Merlie JP, Isenberg KE, Russell SD, Sanes JR: Denervation supersensitivity in skeletal muscle: analysis with a cloned cDNA probe. J Cell Biol 1984;99:332-335. (Pubitemid 14096898)
55. Koishi K, Zhang M, McLennan IS, Harris AJ: MyoD protein accumulates in satellite cells and is neurally regulated in regenerating myotubes and skeletal muscle fibers. Dev Dyn 1995;202:244-254.
56. Weis J: Jun, Fos, MyoD1, and myogenin proteins are increased in skeletal muscle fiber nuclei after denervation. Acta Neuropathol 1994;87:63-70.
57. Zammit PS, Carvajal JJ, Golding JP, Morgan JE, Summerbell D, Zolnerciks J, Partridge TA, Rigby PW, Beauchamp JR: Myf5 expression in satellite cells and spindles in adult muscle is controlled by separate genetic elements. Dev Biol 2004;273:454-465. (Pubitemid 39140915)
58. Kostrominova TY, Macpherson PC, Carlson BM, Goldman D: Regulation of myogenin protein expression in denervated muscles from young and old rats. Am J Physiol Regul Integr Comp Physiol 2000;279:R179-R188. (Pubitemid 30625432)
59. Hegedus J, Putman CT, Tyreman N, Gordon T: Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol 2008;586:3337-3351. (Pubitemid 352003870)
60. Pun S, Santos AF, Saxena S, Xu L, Caroni P: Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 2006;9:408-419. (Pubitemid 43290971)
61. Chargé SB, Brack AS, Bayol SA, Hughes SM: MyoD- and nerve-dependent maintenance of MyoD expression in mature muscle fibres acts through the DRR/PRR element. BMC Dev Biol 2008;8:5.
62. Hyatt JP, Roy RR, Baldwin KM, Edgerton VR: Nerve activity-independent regulation of skeletal muscle atrophy: role of MyoD and myogenin in satellite cells and myonuclei. Am J Physiol Cell Physiol 2003;285:C1161-1173.
63. Kosek DJ, Kim JS, Petrella JK, Cross JM, Bamman MM: Efficacy of 3 days/wk resistance training on myofiber hypertrophy and myogenic mechanisms in young vs. older adults. J Appl Physiol 2006;101:531-544. (Pubitemid 44162363)
64. Legerlotz K, Smith HK: Role of MyoD in denervated, disused, and exercised muscle. Muscle Nerve 2008;38:1087-1100.
65. Thayer MJ, Tapscott SJ, Davis RL, Wright WE, Lassar AB, Weintraub H: Positive autoregulation of the myogenic determination gene MyoD1. Cell 1989;58:241-248. (Pubitemid 19191406)
66. Lassar AB, Davis RL, Wright WE, Kadesch T, Murre C, Voronova A, Baltimore D, Weintraub H: Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 1991;66:305-315. (Pubitemid 121001368)
67. Zhou J, Olson EN: Dimerization through the helix-loop-helix motif enhances phosphorylation of the transcription activation domains of myogenin. Mol Cell Biol 1994;14:6232-6243. (Pubitemid 24264453)
68. Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN, Cabrera CV, Buskin JN, Hauschka SD, Lassar AB, et al: Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 1989;58:537-544. (Pubitemid 19203538)
69. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H: The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 1990;61:49-59.
70. Grimm S, Höhn A, Grune T: Oxidative protein damage and the proteasome. Amino Acids 2010, E-pub ahead of print.
71. Ventadour S, Attaix D: Mechanisms of skeletal muscle atrophy. Curr Opin Rheumatol 2006;18:631-635. (Pubitemid 44607419)
72. Léger B, Vergani L, Sorarù G, Hespel P, Derave W, Gobelet C, D'Ascenzio C, Angelini C, Russell AP: Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J 2006;20:583-585. (Pubitemid 46671257)
73. Abu Hatoum O, Gross-Mesilaty S, Breitschopf K, Hoffman A, Gonen H, Ciechanover A, Bengal E: Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: regulation by specific DNA binding. Mol Cell Biol 1998;18:5670-5677. (Pubitemid 28450518)
74. Viñals F, Ventura F: Myogenin protein stability is decreased by BMP-2 through a mechanism implicating Id1. J Biol Chem 2004;279:45766-45772. (Pubitemid 39491568)
75. Glass DJ: Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care 2010;13:225-229.
76. Moresi V, Williams AH, Meadows E, Flynn JM, Potthoff MJ, McAnally J, Shelton JM, Backs J, Klein WH, Richardson JA, Bassel-Duby R, Olson EN: Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 2010;143:35-45.
77. Dobrowolny G, Aucello M, Molinaro M, Musarò A: Local expression of mIgf-1 modulates ubiquitin, caspase and CDK5 expression in skeletal muscle of an ALS mouse model. Neurol Res 2008;30:131-136. (Pubitemid 351768831)
78. Dobrowolny G, Giacinti C, Pelosi L, Nicoletti C, Winn N, Barberi L, Molinaro M, Rosenthal N, Musarò A: Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol 2005;168:193-199. (Pubitemid 40248217)
79. Figueroa A, Cuadrado A, Fan J, Atasoy U, Muscat GE, Muñoz-Canoves P, Gorospe M, Muñoz A: Role of HuR in skeletal myogenesis through coordinate regulation of muscle differentiation genes. Mol Cell Biol 2003;23:4991-5004. (Pubitemid 36793344)
80. Kanekura K, Suzuki H, Aiso S, Matsuoka M: ER stress and unfolded protein response in amyotrophic lateral sclerosis. Mol Neurobiol 2009;39:81-89.
81. Chang Y, Kong Q, Shan X, Tian G, Ilieva H, Cleveland DW, Rothstein JD, Borchelt DR, Wong PC, Lin CL: Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS. PLoS One 2008;3:e2849.
82. Kawai T, Fan J, Mazan-Mamczarz K, Gorospe M: Global mRNA stabilization preferentially linked to translational repression during the endoplasmic reticulum stress response. Mol Cell Biol 2004;24:6773-6787. (Pubitemid 38944356)
83. Kong Q, Lin CL: Oxidative damage to RNA: mechanisms, consequences, and diseases. Cell Mol Life Sci 2010;67:1817-1829.
84. Chen JF, Tao Y, Li J, Deng Z, Yan Z, Xiao X, Wang DZ:microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol 2010;190:867-879.
85. Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, Bassel-Duby R, Sanes JR, Olson EN:microRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009;326:1549-1554.
86. Sweetman D, Goljanek K, Rathjen T, Oustanina S, Braun T, Dalmay T, Munsterberg A: Specific requirements of MRFs for the expression of muscle specific microRNAs, miR-1, miR-206 and miR-133. Dev Biol 2008;321:491-499.
87. Kitzmann M, Carnac G, Vandromme M, Primig M, Lamb NJ, Fernandez A:The muscle regulatory factors MyoD and Myf-5 undergo distinct cell cycle-specific expression in muscle cells. J Cell Biol 1998;142:1447-1459. (Pubitemid 28452595)
88. Lindon C, Montarras D, Pinset C:Cell cycle-regulated expression of the muscle determination factor Myf5 in proliferating myoblasts. J Cell Biol 1998;140:111-118. (Pubitemid 28070899)
89. Miller RJ, Banisadr G, Bhattacharyya BJ: CXCR4 signaling in the regulation of stem cell migration and development. J Neuroimmunol 2008;198:31-38.
90. Ratajczak MZ, Majka M, Kucia M, Drukala J, Pietrzkowski Z, Peiper S, Janowska-Wieczorek A:Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 2003;21:363-371. (Pubitemid 36623177)